Nektar Therapeutics

NKTRNASDAQHealthcare● Active

$56.07

$-1.25(-2.18%)

Market Cap$1.1B

P/E Ratio—

52W High$109

52W Low$7.99

Avg Volume1.0M

Open$57.20

Beta1.15

Overview

Nektar Therapeutics (NKTR) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · NKTR · as of Mar 13, 2026

Latest filing snapshot

+2+3.28%vs prior year

Nektar Therapeutics (NKTR) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

Change (1Y)

Growth % (1Y)

+3.28%

Revenue / Employee

$876.7K

Net Income / Employee

$-2.60M

Market Cap

$1.1B

NKTR Employee Count

1996 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-13	2025-12-31	63	+2	+3.28%
2025-03-14	2024-12-31	61	-76	-55.47%
2024-03-05	2023-12-31	137	-88	-39.11%
2023-02-28	2022-12-31	225	-515	-69.59%
2022-03-01	2021-12-31	740	+22	+3.06%
2021-02-26	2020-12-31	718	-5	-0.69%
2020-02-28	2019-12-31	723	+105	+16.99%
2019-03-01	2018-12-31	618	+109	+21.41%
2018-03-01	2017-12-31	509	+41	+8.76%
2017-03-01	2016-12-31	468	+43	+10.12%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

Inhibrx Biosciences, Inc.

156$1.3B #3

AMLX

Amylyx Pharmaceuticals, Inc.

123$1.1B #4

ORIC

ORIC Pharmaceuticals, Inc.

Nektar TherapeuticsYOU

63$1.1B #7

ELVN

Enliven Therapeutics, Inc.

62$2.1B

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · NKTR peer comparison

About NKTR employees

NKTR Employees · Headcount

Nektar Therapeutics (NKTR) employee data is sourced from the annual SEC 10-K filing. As of 2025, Nektar Therapeutics had 63 full-time employees globally. Full-time employees only. Global consolidated headcount.

Nektar Therapeutics employs 63 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $876,698, reflecting the company's operational efficiency.

Nektar Therapeutics's workforce increased by 2 (3.28%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Nektar Therapeutics's revenue per employee of $876,698 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

NKTR Employees · 5 questions

As of the latest SEC 10-K filing (2025), Nektar Therapeutics had 63 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Nektar Therapeutics employee counthow many employees does Nektar Therapeutics haveNKTR total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-13